Moneycontrol PRO
HomeNewsBusinessStocksMax Healthcare Institute shares rise over 2% on Nifty Midcap 150

Max Healthcare Institute shares rise over 2% on Nifty Midcap 150

Shares of Max Healthcare Institute Limited were trading at Rs 1,251.50, a 2.11% increase from the previous close, in Thursday's session.

August 21, 2025 / 10:59 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shares of Max Healthcare Institute Limited were trading at Rs 1,251.50, a 2.11% increase from the previous close, in Thursday's session as of 10:32 am. The stock is a constituent of the Nifty Midcap 150 index.

    Financial Performance:

    Max Healthcare Institute Limited has demonstrated significant financial growth over the past few years. The consolidated annual revenue has increased consistently, reaching Rs 7,028.46 Crore for the year ending March 2025, compared to Rs 5,406.02 Crore in the previous year. Net profit also saw a rise, reaching Rs 1,075.88 Crore in March 2025 from Rs 1,057.64 Crore in March 2024. The company's earnings per share (EPS) increased to Rs 11.07 in March 2025 from Rs 10.89 in March 2024.

    The following table presents the consolidated annual financial data for key metrics:

    HeadingMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
    RevenueRs 2,504.67 CroreRs 3,931.46 CroreRs 4,562.60 CroreRs 5,406.02 CroreRs 7,028.46 Crore
    Net Profit-Rs 114.50 CroreRs 605.05 CroreRs 1,103.51 CroreRs 1,057.64 CroreRs 1,075.88 Crore
    EPS-Rs 1.59Rs 6.25Rs 11.38Rs 10.89Rs 11.07
    BVPSRs 58.37Rs 64.79Rs 76.31Rs 86.51Rs 96.50
    ROE-Rs 2.43Rs 9.63Rs 14.89Rs 12.57Rs 11.46
    Debt to EquityRs 0.16Rs 0.12Rs 0.08Rs 0.14Rs 0.27

    The consolidated quarterly revenue also showed an increasing trend. The revenue for the quarter-ending June 2025 was Rs 2,027.57 Crore, up from Rs 1,909.74 Crore in the quarter-ending March 2025. The net profit for the same period stood at Rs 307.97 Crore.

    The following table highlights the consolidated quarterly financials:

    HeadingJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
    RevenueRs 1,542.95 CroreRs 1,707.46 CroreRs 1,868.31 CroreRs 1,909.74 CroreRs 2,027.57 Crore
    Net ProfitRs 236.27 CroreRs 281.81 CroreRs 238.80 CroreRs 319.00 CroreRs 307.97 Crore
    EPSRs 2.43Rs 2.90Rs 2.46Rs 3.28Rs 3.17

    Key financial ratios for Max Healthcare Institute Limited as of March 2025 include a basic EPS of Rs 11.07, diluted EPS of Rs 11.01 and a book value per share of Rs 96.50. The company's debt to equity ratio is 0.27, and the interest coverage ratio is 12.15.

    Corporate Actions:

    Max Healthcare Institute Limited has been actively involved in strategic developments. On August 13, 2025, the company announced an agreement to lease for establishing a ~130 bedded built-to-suit hospital at Dehradun, Uttarakhand. Additionally, the company released its earnings update presentation for the quarter ended June 30, 2025, highlighting a 27% year-over-year revenue growth.

    The company announced a final dividend of Rs 1.50 per share (15%) on May 20, 2025, with an effective date of July 4, 2025.

    A Moneycontrol analysis on August 14, 2025, indicated bearish sentiment on the stock.

    Shares of Max Healthcare Institute Limited were trading at Rs 1,251.50, a 2.11% increase from the previous close, in Thursday's session.

    Alpha Desk
    first published: Aug 21, 2025 10:59 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347